TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. Shi Y, Xu Y, Xu Z, Wang H, et al. Cancer Lett 2022;532:215583.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shi Y, Xu Y, Xu Z, Wang H, et al. TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression. Cancer Lett 2022;532:215583.
PMID: 35149175